FNY Partners Fund’s AnaptysBio ANAB Stock Holding History

FNY Partners Fund’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$17K	–	430
2017 Q3	$17K	Buy	+500	New	+$13.5K	﹤0.01%	384

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

FNY Partners Fund's ANAB Position: Q4 2017 in Review

FNY Partners Fund sold out of AnaptysBio (ANAB) in Q4 2017, closing a stake of 500 shares — an estimated $17K sold.

FNY Partners Fund first reported a position in ANAB in Q3 2017 and held it in 1 quarter. The position peaked at $17K in Q3 2017. 116 funds tracked by Wall St. Rank hold ANAB as of Q4 2017.

FNY Partners Fund reported no remaining AnaptysBio position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 500 AnaptysBio shares in Q4 2017, an estimated $17K.
FNY Partners Fund first reported a position in AnaptysBio in Q3 2017 and held it in 1 quarter.
FNY Partners Fund's AnaptysBio position peaked at $17K in Q3 2017.
116 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.